OTLK Outlook Therapeutics, Inc.
Fundamentals / CIK 0001649989 / USDOutlook Therapeutics, Inc. reported $1.41M in revenue and a net loss of $61.12M for the fiscal year ended September 30, 2025, with a 4.0% gross margin and a -3935.9% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open OTLK in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025$1.41M Sep 30, 2025
-
Operating Income FY 2025-$55.64M -3935.9% margin
-
Net Income FY 2025-$61.12M -4324.1% net margin
-
Diluted EPS FY 2025-$0.45 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Jun 30, 2026$11.24M Total debt: $204K
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.41M | -- | -- | -- | -- | -- | $8.15M | $3.09M | $3.81M | $2.98M |
| Cost of Revenue | $1.36M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Gross Profit | $57K | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Research & Development | $27.18M | $41.76M | $26.45M | $42.33M | $38.96M | $26.34M | $23.81M | $18.50M | $23.81M | $32.76M |
| Selling, General & Admin | $39.94M | $29.94M | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | -- | $51.73M | $36.84M | $44.45M | $32.73M | $39.69M | $54.33M |
| Operating Income | -$67.06M | -$71.70M | -$53.13M | -$63.07M | -$51.73M | -$36.84M | -$36.30M | -$29.64M | -$35.88M | -$51.35M |
| EBITDA | -$66.94M | -$71.59M | -$53.08M | -$62.87M | -$51.46M | -$36.62M | -$32.94M | -$26.59M | -$33.19M | -$48.95M |
| Interest Income | $90K | $906K | $971K | -- | -- | -- | -- | -- | -- | -- |
| Interest Expense | -- | $3.16M | $2.53M | -- | -- | $1.76M | $3.47M | $3.89M | $5.63M | $1.85M |
| Income Before Tax | -$63.98M | -$75.36M | -$58.98M | -$66.05M | -$53.16M | -$38.51M | -$37.93M | -$33.74M | -$38.35M | -$53.20M |
| Income Tax Expense | -$1.55M | $2.8K | $2.8K | $2.8K | $2.0K | -$3.27M | -$3.41M | -$3.65M | $502K | $103K |
| Net Income | -$62.42M | -$75.37M | -$58.98M | -$66.05M | -$53.16M | -$35.24M | -$34.52M | -$30.09M | -$38.85M | -$53.30M |
| Basic EPS | -$1.79 | -$4.06 | -$4.72 | -$6.20 | -$7.00 | -$13.40 | -$39.60 | -$195.20 | -$267.20 | -$587.20 |
| Diluted EPS | -$1.79 | -$4.06 | -$4.72 | -$6.20 | -$7.00 | -$13.40 | -$39.60 | -$195.20 | -$288.00 | -$587.20 |
| Basic Shares Outstanding | 34.8M | 18.5M | 12.5M | 10.6M | 7.6M | 3.6M | 909.6K | 246.6K | 150.1K | 107.6K |
| Diluted Shares Outstanding | 34.8M | 18.5M | 12.5M | 10.6M | 7.6M | 3.6M | 909.6K | 246.6K | 150.3K | 107.6K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | $1.51M | -- | -- | -- |
| Cost of Revenue | $17K | $149K | $30K | -- | $440K | -- | -- | -- |
| Gross Profit | -$8.3K | -$22K | -$1.24M | -- | $1.07M | -- | -- | -- |
| Research & Development | $3.25M | $4.50M | $3.63M | $5.98M | $7.13M | $4.41M | $9.66M | $12.52M |
| Selling, General & Admin | $7.55M | $9.50M | $8.61M | $10.33M | $9.68M | $7.98M | $11.95M | -- |
| Operating Income | -$10.81M | -$14.03M | -$13.48M | -$17.31M | -$15.75M | -$12.39M | -$21.61M | -$22.88M |
| EBITDA | -$10.80M | -$14.00M | -$13.45M | -$17.28M | -$15.72M | -$12.36M | -$21.58M | -$22.85M |
| Income Before Tax | -$20.32M | -$4.45M | -- | -- | -$20.15M | -$46.35M | -- | -- |
| Income Tax Expense | -- | -- | -- | -- | -- | $2.8K | -- | -- |
| Net Income | -$20.32M | -$4.45M | -$23.06M | -$13.29M | -$20.15M | -$46.36M | $17.38M | $5.69M |
| Basic EPS | -$0.15 | -$0.05 | -$0.38 | -- | -$0.55 | -$1.50 | $0.72 | -- |
| Diluted EPS | -$0.15 | -$0.05 | -$0.38 | -- | -$0.55 | -$1.50 | $0.72 | -- |
| Basic Shares Outstanding | 136.7M | 81.8M | 60.2M | -- | 37.0M | 30.9M | 24.2M | -- |
| Diluted Shares Outstanding | 136.7M | 81.8M | 60.2M | -- | 37.0M | 30.9M | 24.2M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $8.08M | $14.93M | $23.39M | $17.40M | $14.48M | $12.54M | $8.02M | $1.72M | $3.19M | $2.35M |
| Cash & Short-Term Investments | $8.08M | $14.93M | $23.39M | $17.40M | $14.48M | $12.54M | $8.02M | $1.72M | $3.19M | $2.35M |
| Accounts Receivable, Net | $1.49M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Inventory | $3.34M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Current Assets | $17.39M | $27.42M | $30.98M | $27.52M | $21.51M | $17.94M | $13.50M | $3.30M | $3.90M | $5.68M |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | $164K | $327K | $3.18M | $18.49M | $16.09M | $18.66M |
| Other Non-Current Assets | $418K | $439K | $501K | $132K | $175K | $1.29M | $457K | $491K | $740K | $853K |
| Total Non-Current Assets | $1.20M | $1.41M | $1.32M | $1.01M | $1.30M | $1.79M | $3.63M | $18.98M | $16.83M | $19.73M |
| Total Assets | $18.58M | $28.82M | $32.30M | $28.53M | $22.81M | $19.73M | $17.13M | $22.28M | $20.73M | $25.41M |
| Accounts Payable | $10.19M | $7.97M | $6.57M | $3.49M | $2.20M | $2.39M | $2.28M | $3.61M | $10.95M | $5.07M |
| Short-Term Debt | -- | -- | -- | -- | -- | -- | $1.03B | $66K | $53K | $586K |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | -- | $1.74M | $3.09M | $1.21M |
| Total Current Liabilities | $45.81M | $42.55M | $46.73M | $19.73M | $6.75M | $15.89M | $20.29M | $32.04M | $28.74M | $20.44M |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | $50.28M | $98K | $151K | $2.23M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | -- | $2.76M | $4.47M | $5.15M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | $3.94M | $3.51M | $2.57M | $2.43M |
| Total Non-Current Liabilities | $4.96M | $59.35M | $6.2K | $61K | $11.45M | $1.02M | $7.61M | $11.05M | $22.72M | $10.14M |
| Total Liabilities | $50.77M | $101.9M | $46.74M | $19.79M | $18.20M | $16.91M | $27.90M | $43.09M | $51.46M | $30.58M |
| Total Debt (incl. Leases) | $248K | $298K | $4.3K | $43K | $112K | $260K | $1.08B | $165K | $204K | $2.82M |
| Common Stock | $539K | $239K | $130K | $2.27M | $1.76M | $1.27M | $286K | $90K | $249K | $228K |
| Retained Earnings | -$605.7M | -$543.3M | -$467.9M | -$408.9M | -$342.9M | -$289.7M | -$254.5M | -$216.3M | -$186.2M | -$147.4M |
| Total Stockholders' Equity | -$32.19M | -$73.08M | -$14.44M | $8.74M | $4.61M | $2.83M | -$16.13M | -$25.54M | -$33.65M | -$5.17M |
| Total Equity | -$32.19M | -$73.08M | -$14.44M | $8.74M | $4.61M | $2.83M | -$16.13M | -$25.54M | -$33.65M | -$5.20M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $11.24M | $7.75M | $8.68M | $8.08M | $8.90M | $7.56M | $5.70M | $14.93M |
| Cash & Short-Term Investments | $11.24M | $7.75M | $8.68M | $8.08M | $8.90M | $7.56M | $5.70M | $14.93M |
| Accounts Receivable, Net | $1.64M | $2.72M | $115K | $1.49M | $1.75M | -- | -- | -- |
| Inventory | $5.04M | $3.34M | $3.46M | $3.34M | $4.13M | $3.60M | $3.11M | -- |
| Total Current Assets | $23.17M | $20.90M | $17.17M | $17.39M | $21.10M | $17.81M | $15.67M | $27.42M |
| Other Non-Current Assets | $304K | $320K | $346K | $418K | $464K | $394K | $416K | $439K |
| Total Non-Current Assets | $3.02M | $988K | $1.07M | $1.20M | $1.30M | $1.27M | $1.34M | $1.41M |
| Total Assets | $26.18M | $21.89M | $18.24M | $18.58M | $22.39M | $19.08M | $17.01M | $28.82M |
| Accounts Payable | $6.81M | $13.64M | $7.32M | $10.19M | $10.26M | $7.77M | $12.19M | $7.97M |
| Total Current Liabilities | $28.68M | $38.88M | $49.06M | $45.81M | $31.49M | $24.82M | $48.24M | $42.55M |
| Total Non-Current Liabilities | $7.90M | $12.00M | $7.73M | $4.96M | $28.09M | $26.72M | $19.06M | $59.35M |
| Total Liabilities | $36.58M | $50.89M | $56.79M | $50.77M | $59.58M | $51.54M | $67.30M | $101.9M |
| Total Debt (incl. Leases) | $204K | $219K | $233K | $248K | $261K | $273K | $286K | $298K |
| Common Stock | $1.87M | $1.05M | $646K | $539K | $435K | $329K | $249K | $239K |
| Retained Earnings | -$653.5M | -$633.2M | -$628.8M | -$605.7M | -$592.4M | -$572.3M | -$525.9M | -$543.3M |
| Total Stockholders' Equity | -$10.39M | -$28.99M | -$38.55M | -$32.19M | -$37.19M | -$32.46M | -$50.29M | -$73.08M |
| Total Equity | -$10.39M | -$28.99M | -$38.55M | -$32.19M | -$37.19M | -$32.46M | -$50.29M | -$73.08M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$62.42M | -$75.37M | -$58.98M | -$66.05M | -$53.16M | -$35.24M | -$34.52M | -$30.09M | -$38.85M | -$53.33M |
| Depreciation & Amortization | $117K | $114K | $44K | $205K | $262K | $219K | $3.36M | $3.05M | $2.69M | $2.39M |
| Stock-Based Compensation | $8.90M | $5.39M | $5.55M | $7.71M | $4.89M | $2.81M | $1.31M | $1.99M | $8.57M | $12.45M |
| Change in Receivables | -$1.49M | -- | -- | -- | -- | -- | -- | -- | -- | $20K |
| Change in Inventory | -$3.34M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Change in Payables | $1.67M | $1.39M | $3.08M | $1.30M | -$198K | -$1.49M | -$1.33M | -$6.71M | $5.73M | -$5.33M |
| Operating Cash Flow | -$51.83M | -$68.79M | -$42.97M | -$56.67M | -$54.25M | -$31.79M | -$32.29M | -$33.04M | -$15.51M | -$45.48M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -$437K | -$2.78M | -$292K | -$1.10M |
| Free Cash Flow | -- | -- | -- | -- | -- | -- | -$32.73M | -$35.82M | -$15.80M | -$46.58M |
| Investing Cash Flow | -- | -- | -- | -- | -- | -$900K | -$437K | -$2.78M | -$292K | -$1.10M |
| Common Stock Issued | $25.40M | $60.33M | $30.02M | $62.31M | $46.30M | $35.43M | $45.96M | $14.70M | $1.61M | $16.14M |
| Financing Cash Flow | $44.98M | $60.33M | $48.97M | $59.59M | $56.19M | $37.21M | $39.03M | $34.35M | $16.63M | $39.86M |
| Net Change in Cash | -$6.84M | -$8.46M | $6.00M | $2.92M | $1.94M | $4.52M | $6.30M | -$1.47M | $834K | -$6.72M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$20.32M | -$4.45M | -$23.06M | -$13.29M | -$20.15M | -$46.36M | $17.38M | $5.69M |
| Depreciation & Amortization | $14K | $30K | $30K | $30K | $29K | $29K | $29K | $29K |
| Stock-Based Compensation | $792K | $757K | $881K | $1.82M | $1.68M | $1.72M | $3.67M | $1.41M |
| Change in Receivables | $1.08M | -$2.61M | $1.38M | -- | -- | -- | -- | -- |
| Change in Inventory | -$1.70M | $114K | -$120K | $788K | -$522K | -$495K | -$3.11M | -- |
| Change in Payables | -$6.46M | $5.71M | -$2.87M | $30K | $2.04M | -$4.63M | $4.22M | $2.53M |
| Operating Cash Flow | -$21.01M | -$7.83M | -$14.94M | -$12.38M | -$11.90M | -$16.58M | -$10.97M | -$16.98M |
| Common Stock Issued | $25.20M | $6.90M | $14.93M | $7.64M | $14.60M | $1.42M | $1.74M | -- |
| Financing Cash Flow | $26.60M | $6.90M | $15.53M | $11.56M | $13.25M | $18.44M | $1.74M | -$115K |
| Net Change in Cash | $3.49M | -$929K | $594K | -$818K | $1.34M | $1.85M | -$9.22M | -$17.10M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 4.0% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating Margin | -4744.3% | -- | -- | -- | -- | -- | -445.6% | -960.1% | -941.4% | -1723.3% |
| Net Profit Margin | -4416.2% | -- | -- | -- | -- | -- | -423.8% | -974.6% | -1019.3% | -1788.9% |
| Return on Equity (ROE) | -- | -- | -- | -756.0% | -1153.9% | -1246.8% | -- | -- | -- | -- |
| Return on Assets (ROA) | -335.9% | -261.5% | -182.6% | -231.5% | -233.1% | -178.6% | -201.5% | -135.0% | -187.4% | -209.8% |
| Current Ratio | 0.38x | 0.64x | 0.66x | 1.39x | 3.19x | 1.13x | 0.67x | 0.10x | 0.14x | 0.28x |
| Quick Ratio | 0.31x | 0.35x | 0.50x | 0.88x | 2.14x | 0.79x | 0.40x | 0.05x | 0.11x | 0.12x |
| Debt to Equity | -- | -- | -- | 0.00x | 0.02x | 0.09x | -- | -- | -- | -- |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | -- | +163.8% | -19.0% | +27.9% | -42.9% |
| 10Y Revenue / Share Growth | -100.0% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Return on Assets (ROA) | -233.4% | -278.4% | -564.0% | -335.9% | -194.0% | 110.7% | -275.3% | -261.5% |
| Current Ratio | 0.81x | 0.54x | 0.35x | 0.38x | 0.67x | 0.72x | 0.32x | 0.64x |
| Quick Ratio | 0.63x | 0.45x | 0.28x | 0.31x | 0.54x | 0.57x | 0.26x | 0.35x |
| Gross Profit Growth (YoY) | -100.8% | -- | -- | -- | -- | -- | -- | -- |
| Net Income Growth (YoY) | -- | -- | -232.7% | -333.6% | -145.4% | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -152.8% | -- | -128.8% | -- | -- | -- |